Figure 6
Figure 6. Inhibitors of Hsp90 and the proteasome result in different caspase cleavage patterns. Cells were treated with the IC50 doses of each inhibitor (17-AAG, 5 μM; radicicol, 10 μM, and bortezomib, 8 nM) for a 24-hour treatment period, lysed and samples analyzed by immunoblotting. Representative cell line data on U266 are shown. All experiments were repeated in triplicate.

Inhibitors of Hsp90 and the proteasome result in different caspase cleavage patterns. Cells were treated with the IC50 doses of each inhibitor (17-AAG, 5 μM; radicicol, 10 μM, and bortezomib, 8 nM) for a 24-hour treatment period, lysed and samples analyzed by immunoblotting. Representative cell line data on U266 are shown. All experiments were repeated in triplicate.

Close Modal

or Create an Account

Close Modal
Close Modal